Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Big news from MGC today with the listing of ArtemiC as an over-the-counter drug by the FDA and an order for ArtemiC of US$2,000,000
Key points:
· ArtemiC™ has now been listed as an over-the-counter, non-prescription drug status in the USA, following the listing on the FDA National Drug Code Database .
· ArtemiC™ is to be sold at US Pharmacy Benefit Management (PBM) networks from April 2023, with other independent outlets still in talks with AMC
· Following the NDC Listing, AMC have placed a purchase order for ArtemiC™ to the value of US$2,000,000
· AMC Holdings, Inc. is a Special Purpose Vehicle founded by experienced US healthcare professionals and former federal US government officials to facilitate the research and growth of phyto-medicines in the USA, and sees MGC Pharma as a leader in the sector for the domestic market
· ArtemiC™ Phase II Clinical Trial undertaken in 2020[1], demonstrated a range of benefits for patients suffering from moderate COVID-19. Subsequent trials have proven ArtemiC™ to be an effective anti-inflammatory across a wide range of chronic diseases
* OTC status means that AMC will be able to sell ArtemiC™ via US-based Pharmacy Benefit Management (PBM) networks, including prescription discount services, from April 2023. AMC are negotiating with the largest US Pharmacy networks, and independent pharmacies for the inclusion of ArtemiC™ in shelf space now that the NDC has been listed. This nation-wide availability across the country will increase retail access and subsequent sales.
* Further to this, AMC have submitted a purchase order for US$2m of ArtemiC™, with production to commence immediately.
Excellent news today. We are on the launchpad now....
Good luck, Brighty
We should be hearing encouraging news shortly on MGC distributing the first CannEpil units to EU territories and the UK during Q1 2023. See full details at:
https://www.asx.com.au/asxpdf/20230228/pdf/45m5r4hpgs6nb8.pdf
Good luck, Brighty
In addition to the brilliant OTC RNS today about CimetrA it is also worth pointing out that MGC has announced two excellent clinical results demonstrating full safety and preliminary efficacy profiles in Dementia treatment with CogniCann® and Glioblastoma for tumours. A licencing deal or even M&A activity must be on the cards in due course. Hopefully 2023 will be the year when R&D Depts at big pharma cotton on to what is unfolding here. This is getting more and more interesting with every RNS issued. Good luck, Brighty
50% up today already on this news. Encouraging to note that other US independent outlets are also in talks with AMC following the granting of Over The Counter status by the FDA. That $2Million AMC order looks likely to increase by many multiples moving forward....Good luck, Brighty